|
LRSAM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.278000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.141400E-01 |
| Normal-vs-Stage2 |
9.187600E-01 |
| Normal-vs-Stage3 |
5.017000E-01 |
| Normal-vs-Stage4 |
9.027600E-01 |
| Stage1-vs-Stage2 |
9.712800E-01 |
| Stage1-vs-Stage3 |
3.470000E-01 |
| Stage1-vs-Stage4 |
9.595400E-01 |
| Stage2-vs-Stage3 |
5.235800E-01 |
| Stage2-vs-Stage4 |
9.907600E-01 |
| Stage3-vs-Stage4 |
4.804000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.114800E-01 |
| Normal-vs-AfricanAmerican |
3.74520000001599E-06 |
| Normal-vs-Asian |
1.171040E-01 |
| Caucasian-vs-AfricanAmerican |
1.63470004199695E-09 |
| Caucasian-vs-Asian |
9.813900E-02 |
| AfricanAmerican-vs-Asian |
4.650800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.625200E-01 |
| Normal-vs-Female |
1.873990E-01 |
| Male-vs-Female |
2.361500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.675000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.774800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.475600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.447400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.888200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.292000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.314600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.279600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.743200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.680800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.718170E-03 |
| Normal-vs-Grade 2 |
8.555000E-01 |
| Normal-vs-Grade 3 |
8.041400E-01 |
| Normal-vs-Grade 4 |
4.163800E-01 |
| Grade 1-vs-Grade 2 |
4.462900E-03 |
| Grade 1-vs-Grade 3 |
3.358000E-03 |
| Grade 1-vs-Grade 4 |
6.441600E-03 |
| Grade 2-vs-Grade 3 |
5.529600E-01 |
| Grade 2-vs-Grade 4 |
2.876800E-01 |
| Grade 3-vs-Grade 4 |
4.633600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.430400E-01 |
| Normal-vs-ccB subtype |
1.517520E-02 |
| ccA subtype-vs-ccB subtype |
5.402200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.368000E-01 |
| Normal-vs-N1 |
3.083200E-01 |
| N0-vs-N1 |
2.340000E-01 |
|
|
